Vericel’s MACI Sets Second Quarter Revenue Record

Vericel reported 2Q24 orthopedic sales of $44.1 million, up 21.5% from the second quarter of 2023. For the year's first half, the company generated $84.3 million in orthopedic sales, up 19.6% from last year.

The company set a second-quarter record for MACI sales and saw the second-highest number of MACI biopsies, including the highest...

document icon

You’ve reached your limit.

We’re glad you’re finding value in our content — and we’d love for you to keep going.

Subscribe now for unlimited access to orthopedic business intelligence.

ME

Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.



Contact Us

0